Guilin Sanjin: 002275 Guilin Sanjin Investor Relations Management Information 20240906
Guilin Sanjin: 002275 Guilin Sanjin Investor Relations Management Information 20240905
Guilin Sanjin: Announcement on progress in providing guarantees for Sun Company
Guilin Sanjin: 002275 Guilin Sanjin Investor Relations Management Information 20240904
Guilin Sanjin: 002275 Guilin Sanjin Investor Relations Management Information 20240830
Guilin Sanjin: 002275 Guilin Sanjin Investor Relations Management Information 20240903
Guilin Sanjin: Legal Opinion of Beijing Commerce Law Firm on the actual controller, chairman and president of Guilin Sanjin Pharmaceutical Co., Ltd. increasing the company\'s shares
Guilin Sanjin: Announcement on the completion of the plan to increase the shareholding of the company\'s actual controller, chairman and president
Guilin Sanjin: Semi-Annual Report 2024
Guilin Sanjin: Announcement on providing guarantees for wholly-owned subsidiaries
Guilin Sanjin: Semi-annual Non-Operating Capital Occupancy and Other Related Capital Transactions Summary
Guilin Sanjin: 2024 Semi-Annual Financial Report
Guilin Sanjin: 2024 Semi-Annual Report Summary
Guilin Sanjin: Semi-Annual Report Board Resolution Announcement
Guilin Sanjin Pharmaceutical: Announcement regarding the subsidiary obtaining approval for drug clinical trials.
Guilin Sanjin Pharmaceutical: 002275 Guilin Sanjin Investor Relations Management Information 20240710
Guilin Sanjin Pharmaceutical: Investor Relations Management Information of Guilin Sanjin Pharmaceutical on July 8th, 2024.
Guilin Sanjin Pharmaceutical: Investor Relations Management Information for Guilin Sanjin Pharmaceuticals on July 2, 2024.
Guilin Sanjin Pharmaceutical: Investor relations management information for Guilin Sanjin on June 28, 2024.
Guilin Sanjin Pharmaceutical: Investor Relations Management Information for Guilin Sanjin Pharmaceuticals on June 26, 2024
No Data
No Data